SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000926617-21-000044
Filing Date
2021-05-07
Accepted
2021-05-07 17:08:54
Documents
3
Period of Report
2021-05-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A awh-20210507xdef14a.htm DEF 14A 770594
2 GRAPHIC awh-20210507xdef14ag001.jpg GRAPHIC 101814
3 GRAPHIC awh-20210507xdef14ag002.jpg GRAPHIC 120964
  Complete submission text file 0000926617-21-000044.txt   1079040
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34810 | Film No.: 21903857
SIC: 2835 In Vitro & In Vivo Diagnostic Substances